Our Review Summary
WebMD fell short of the competing LA Times story in reporting on this study.
This story gives a limited perspective on the new trial data that leave the reader thinking it probably works, without drawing the limitations into question. The single independent comment does not deal with the study’s “science” but rather the need for new and effective treatments.
Why This Matters
Menopausal symptoms are extremely common (as stated by the writer) and bothersome. New therapies that are non-pharmacologic are welcome, if they are effective.
Criteria
Not Satisfactory
The story does not detail the costs of the weekly sessions of therapeutic hypnosis, which are likely to be high.
Not Satisfactory
The story leads by saying that “alternative therapy reduced hot flashes by as much as 74%” and later that “Women in the hypnosis group reported 74% fewer hot flashes on average, compared with 17% fewer among the other women.” But the story doesn’t explain “74% of what?” – from what to what? That’s what’s needed in order to judge the potential scope of the benefit in terms that are most meaningful to readers.
Not Satisfactory
The story does not describe any possible harms or side effects of the alternative therapy. It does, however, mention that hormone therapy comes with its own risks. The LA Times article, by comparison, correctly states there is no known risk of hypnosis.
Not Satisfactory
The article fails to mention any limitations in the study, such as its small study size and short duration. Furthermore, although the study was randomized, it was not double-blind. And how long did the effects last? Would patients have to undergo hypnosis for the rest of their lives to experience fewer hot flashes?
Satisfactory
The story does not engage in disease mongering.
Not Satisfactory
The WebMD quotes a researcher tied to the study and the Executive Director of the North American Menopause Society (NAMS). The study was published in Menopause, which is the journal of NAMS. A comment from an independent source would have been welcome, especially if he/she discussed the study’s limitations and significance. Furthermore, any potential conflicts of interest are not mentioned.
Not Satisfactory
The story mentions hormone therapy as an effective treatment with risks, but does not go further into detail. The researcher is quoted as saying in the article, “Only hormone therapy, which many women can’t take or want to avoid, is more effective for treating the most common symptom of menopause.” But how much more effective is hormone therapy? And what exactly are the risks? The researcher also adds that therapeutic hypnosis works “as well or better” than antidepressants or other non-hormonal therapies, but it would have helped if the story specifically described the non-hormonal alternatives.
The LA Times article gave a better description of the other complementary/alternative medicine treatments.
Not Satisfactory
It wasn’t clear whether a clinician could conduct the self-hypnosis trainings, or whether the patient needed to find another certified professional. And how were the hypnotic recordings obtained? Towards the end, the story does include the comment about finding a qualified hypotherapist. But readers aren’t given any sense of how easy/difficult that might be.
Satisfactory
The story mentions that researchers conducted a similar trial in breast cancer patients with treatment-related symptoms. Researchers now wanted to see whether a similar approach could help women whose symptoms were related to menopause. That was good context.
Satisfactory
The story does not rely on a press release. There is evidence of original reporting, with the two comments from the researcher and the NAMS director.
Total Score: 3 of 10 Satisfactory
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like